These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2748712)

  • 1. [Synthesis, detection and pharmacokinetic behavior of pholedrine sulphate esters. 7. Comparison of free- and sustained-release tablets in vivo and in vitro].
    Fürst W; Neubert R; Petzsche M; Noll E
    Pharmazie; 1989 Mar; 44(3):234. PubMed ID: 2748712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preparation, detection and pharmacokinetic behavior of pholedrine sulfuric acid ester. 6. Determination of pholedrine and pholedrine sulfuric acid esters in plasma after oral administration of pholedrine].
    Petzsche M; Fürst W; Fahr A; Sziegoleit W
    Pharmazie; 1988 Dec; 43(12):875. PubMed ID: 3247384
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation, detection and pharmacokinetic behavior of pholedrine sulfuric acid esters. 3. Determination of free and bound pholedrine in urine].
    Petzsche M; Noll E; Hartung S; Fürst W
    Pharmazie; 1988 Apr; 43(4):291. PubMed ID: 3413223
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation, detection and pharmacokinetic behavior of pholedrine sulfuric acid ester. 5. Methods for determining pholedrine and pholedrine sulfuric acid esters in plasma].
    Petzsche M; Fürst W
    Pharmazie; 1988 Dec; 43(12):867-8. PubMed ID: 3247382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preparation, detection and pharmacokinetic behavior of pholedrine sulfuric acid ester. 2. Transformation of pholedrin and pholedrin sulfuric acid esters with dinitroflorobenzene].
    Petzsche M; Fürst W
    Pharmazie; 1988 Feb; 43(2):135. PubMed ID: 3393585
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preparation, detection and pharmacokinetic behavior of pholedrine sulfuric acid esters. 4. Detection and determination of pholedrine sulfuric acid esters in urine].
    Petzsche M; Fürst W
    Pharmazie; 1988 Apr; 43(4):291-2. PubMed ID: 3413224
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preparation of peroral delayed-action drug forms using biological polymers as the base. 4. Preparation of erosion tablets with a base of starch hydrolysis products].
    Mank R; Kala H; Lorenz A
    Pharmazie; 1989 Sep; 44(9):617-8. PubMed ID: 2608707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Production, analysis and pharmacokinetic behavior of pholedrin sulfuric acid esters. 1. Production and analysis of pholedrin sulfuric acid esters].
    Petzsche M; Neubert R; Fürst W
    Pharmazie; 1988 Jan; 43(1):46-7. PubMed ID: 3375302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of poly(meth)acrylates for the control and release of pholedrine sulfate from microdragees].
    Hennig D; Kala H
    Pharmazie; 1985 Aug; 40(8):554-7. PubMed ID: 4080801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ion-pair-formation on the pharmacokinetic properties of drugs. Part 3: Influence of hexylsalicylic acid on the pharmacokinetics of pholedrine.
    Neubert R; Albrecht G; Taube C; Weiss M; Fürst W
    Pharmazie; 1988 Sep; 43(9):632-3. PubMed ID: 3244733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained-release tablets of indomethacin-loaded microcapsules: preparation, in vitro and in vivo characterization.
    Lu B; Wen R; Yang H; He Y
    Int J Pharm; 2007 Mar; 333(1-2):87-94. PubMed ID: 17081709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The study of the in vivo-in vitro correlation of the naftopidil sustained-release tablet in dog].
    Jia Y; Jiang X; Ding J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Aug; 23(4):826-8, 843. PubMed ID: 17002117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
    Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
    Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride.
    Feng XM; Ren Q; Zhang WZ; Shen HF; Rong ZX; Fang C; Chen HZ
    J Pharm Pharmacol; 2008 Jul; 60(7):817-22. PubMed ID: 18549667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of ofloxacin sustained release pellets.
    Cui Y; Zhang Y; Tang X
    Int J Pharm; 2008 Aug; 360(1-2):47-52. PubMed ID: 18538518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and in vitro/in vivo evaluation of sustained-release metformin hydrochloride pellets.
    Hu LD; Liu Y; Tang X; Zhang Q
    Eur J Pharm Biopharm; 2006 Oct; 64(2):185-92. PubMed ID: 16797948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.